100817-89-8

Basic information

• Product Name: Acetamide, N-(4-methyl-2-benzothiazolyl)- (9CI)
• Synonyms: Acetamide, N-(4-methyl-2-benzothiazolyl)- (9CI);N-(4-methylbenzo[d]thiazol-2-yl)acetamide
• CAS NO: 100817-89-8
• Molecular Formula: C10H10N2OS
• Molecular Weight: 206.2642
• Product Categories: BENZOTHIAZOLE
• Mol File: 100817-89-8.mol

Chemical Properties

• Appearance: /
• Density: 1.325±0.06 g/cm3(Predicted)
• PKA: 10.84±0.70(Predicted)
• CAS DataBase Reference: Acetamide, N-(4-methyl-2-benzothiazolyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(4-methyl-2-benzothiazolyl)- (9CI)(100817-89-8)
• EPA Substance Registry System: Acetamide, N-(4-methyl-2-benzothiazolyl)- (9CI)(100817-89-8)

Safety Data

• Hazardous Substances Data: 100817-89-8(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 1477-42-5 4-methyl-1,3-benzothiazol-2-amine 
• 64-19-7 acetic acid 
• 14185-60-5 N-acetyl-N'-o-tolyl-thiourea 
• 95-53-4 o-toluidine 
• 127-19-5 N,N-dimethyl acetamide 

Downstream Products

• 3048-48-4 4-methylbenzo[d]thiazole 

Relevant articles and documents

Imidazolium chloride: An efficient catalyst for transamidation of primary amines

A highly efficient and convenient protocol of imidazolium chloride (30 mol %) catalyzed amidation of amines with moderate to excellent yields was reported. The protocol shows broad substrate scope for aromatic, aliphatic, and heterocyclic primary amines.

Synthesis of N-benzothiazol-2-yl-amides by an iron-catalyzed oxidative C(sp2)-H functionalization

Catalytic synthesis of N-benzothiazol-2-yl-amides from 1-acyl-3-(phenyl) thioureas was achieved in the presence of an iron catalyst through C(sp 2)-H functionalization and C-S bond formation. Various N-benzothiazol-2-yl-amides were selectively obtained in good yields. Georg Thieme Verlag Stuttgart, New York.

Synthesis of N-benzothiazol-2-yl-amides by Pd-catalyzed C(sp2)-H functionalization

A catalytic synthesis of N-benzothiazol-2-yl-amides from 1-acyl-3-(phenyl)thioureas was achieved in the presence of a palladium catalyst through the C(sp2)-H functionalization/C-S bond formation. This synthetic methodology can produce various N

(3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides and 3-amino-N-(4-aryltetrahydropyran-4-yl)butanamides were synthesized and evaluated as dipeptidyl peptidase IV (DPP-IV) inhibitors. Derivatives incorporating the 6-substituted benzothiazole group showed highly potent DPP-IV inhibitory activity. Oral administration of (3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide (12u) reduced blood glucose excursion in an oral glucose tolerance test.